Skip to content
Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

YOUR GENOME HAS BEEN MARKED DOWN

By Bennett Davis
Veritas Genetics, a Boston-area gene sequencing company, has reduced the price for sequencing and interpreting an entire human genome from $999 to $599.
For the price, Veritas will not only apply the power of artificial intelligence to sequence your genome but also give you an expert reading, highlighting genetic propensities for 200 specific diseases as well as traits that may lurk in your or your children’s future, such as male pattern baldness.
The company is among the first that sequences all 6.4 billion “letters” in a person’s genetic code. Others offering similar services, such as 23andMe, use a process called genotyping that looks only at specific points in a genome, often examining less than 1 percent of the whole.
If $599 is still too high a price, nearby Nebula Genomics will sequence your genome for $299 or perhaps even for free – if you’re willing to share the results with pharmaceutical companies and other medical researchers.
TRENDPOST: Companies want your genetic data not only to provide a profitable service but also to amass millions of genomes for researchers to sort through to find patterns that define specific diseases, abnormalities, and traits.
That’s a noble goal. But geneticists aren’t security experts.
Veritas reported a digital security “breach” last November, although it claimed no clients’ data were stolen.
Police departments have knocked on genome databases’ doors with warrants authorizing scrutiny of clients’ information in hopes of matching DNA evidence to individuals.
If you offer up your genome to a private company or research organization, get in writing a statement of how your data will be sold or shared, how you can monitor compliance, and be aware that the security of your genetic information cannot be guaranteed.